Bryce A. Roberts
Fondateur chez Arbutus Biopharma, Inc.
Profil
Bryce A.
Roberts has founded Arbutus Biopharma, Inc. in 2012, where he currently holds the title of Chief Legal Officer & Head-Administration.
He has previously worked as Secretary & Director-Legal Affairs at Pharmasset, Inc. and as Vice President & Senior Counsel at Gilead Sciences, Inc. Mr. Roberts has an undergraduate degree from the University of Georgia and a graduate degree from Georgia State University College of Law.
Postes actifs de Bryce A. Roberts
| Sociétés | Poste | Début |
|---|---|---|
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Fondateur | 01/05/2012 |
Anciens postes connus de Bryce A. Roberts
| Sociétés | Poste | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Conseiller Juridique Général | - |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Conseiller Juridique Général | - |
Formation de Bryce A. Roberts
| Georgia State University College of Law | Graduate Degree |
| University of Georgia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
